Dr. Allan E. Gross, C.M., is an internationally recognized pioneer in complex joint transplant surgery. His innovative techniques are now routinely performed in specialized orthopaedic centres worldwide, restoring quality of life to patients of all ages.
His trailblazing work utilized donor bone and soft tissue for post-traumatic joint repair, transforming orthopaedic care with the world’s first fresh-tissue knee transplant in 1972, followed by Canada’s first fresh-tissue hip transplant five years later.
As revision arthroplasty—joint transplant “do-overs” for patients with failing artificial implants—arrived on the scene in the early 1980s, it became apparent that some of these surgeries also required restoration of adjoining bone tissue. Dr. Gross was instrumental in the establishment of Canada’s largest bone and tissue bank, securing Mount Sinai’s preeminence as a leading referral centre and training ground for specialized orthopaedic care.
In addition to advancing the field with techniques for harvesting, processing and implanting fresh tissue, Dr. Gross's expertise also informed the design of instrumentation and implants to be used specifically for bone transplantation when performing revision arthroplasty of the hip. As a result of his innovations, cartilage transplantation is now routinely performed in specialized orthopaedic centres worldwide.
His contributions paved the way for the growth of one of the world’s most comprehensive orthopaedic surgery programs. Today, Sinai Health’s Division of Orthopadeic Surgery is recognized internationally for its leadership in complex orthopaedic surgery, its preeminence in orthopaedic oncology and limb-sparing surgery for bone cancer patients, as well as its excellence in orthopaedic sports medicine.
Dr. Gross has published four books, 60 chapters and over 260 articles, and has been cited as one of the world’s most influential authors in revision arthroplasty of the hip. He was appointed Head of the Division of Orthopaedic Surgery at Mount Sinai in 1973 and Chief of Surgery in 1975. He was the orthopaedic surgeon for the Toronto Blue Jays from 1981-2017, serving as a member of the 1992 and 1993 World Series teams. He was appointed to the Order of Canada in 2022 for “significant advancements in bone and cartilage transplantation as a renowned orthopaedic surgeon, educator and researcher.”
His trailblazing work utilized donor bone and soft tissue for post-traumatic joint repair, transforming orthopaedic care with the world’s first fresh-tissue knee transplant in 1972, followed by Canada’s first fresh-tissue hip transplant five years later.
As revision arthroplasty—joint transplant “do-overs” for patients with failing artificial implants—arrived on the scene in the early 1980s, it became apparent that some of these surgeries also required restoration of adjoining bone tissue. Dr. Gross was instrumental in the establishment of Canada’s largest bone and tissue bank, securing Mount Sinai’s preeminence as a leading referral centre and training ground for specialized orthopaedic care.
In addition to advancing the field with techniques for harvesting, processing and implanting fresh tissue, Dr. Gross's expertise also informed the design of instrumentation and implants to be used specifically for bone transplantation when performing revision arthroplasty of the hip. As a result of his innovations, cartilage transplantation is now routinely performed in specialized orthopaedic centres worldwide.
His contributions paved the way for the growth of one of the world’s most comprehensive orthopaedic surgery programs. Today, Sinai Health’s Division of Orthopadeic Surgery is recognized internationally for its leadership in complex orthopaedic surgery, its preeminence in orthopaedic oncology and limb-sparing surgery for bone cancer patients, as well as its excellence in orthopaedic sports medicine.
Dr. Gross has published four books, 60 chapters and over 260 articles, and has been cited as one of the world’s most influential authors in revision arthroplasty of the hip. He was appointed Head of the Division of Orthopaedic Surgery at Mount Sinai in 1973 and Chief of Surgery in 1975. He was the orthopaedic surgeon for the Toronto Blue Jays from 1981-2017, serving as a member of the 1992 and 1993 World Series teams. He was appointed to the Order of Canada in 2022 for “significant advancements in bone and cartilage transplantation as a renowned orthopaedic surgeon, educator and researcher.”
His trailblazing work utilized donor bone and soft tissue for post-traumatic joint repair, transforming orthopaedic care with the world’s first fresh-tissue knee transplant in 1972, followed by Canada’s first fresh-tissue hip transplant five years later.
As revision arthroplasty—joint transplant “do-overs” for patients with failing artificial implants—arrived on the scene in the early 1980s, it became apparent that some of these surgeries also required restoration of adjoining bone tissue. Dr. Gross was instrumental in the establishment of Canada’s largest bone and tissue bank, securing Mount Sinai’s preeminence as a leading referral centre and training ground for specialized orthopaedic care.
In addition to advancing the field with techniques for harvesting, processing and implanting fresh tissue, Dr. Gross's expertise also informed the design of instrumentation and implants to be used specifically for bone transplantation when performing revision arthroplasty of the hip. As a result of his innovations, cartilage transplantation is now routinely performed in specialized orthopaedic centres worldwide.
His contributions paved the way for the growth of one of the world’s most comprehensive orthopaedic surgery programs. Today, Sinai Health’s Division of Orthopadeic Surgery is recognized internationally for its leadership in complex orthopaedic surgery, its preeminence in orthopaedic oncology and limb-sparing surgery for bone cancer patients, as well as its excellence in orthopaedic sports medicine.
Dr. Gross has published four books, 60 chapters and over 260 articles, and has been cited as one of the world’s most influential authors in revision arthroplasty of the hip. He was appointed Head of the Division of Orthopaedic Surgery at Mount Sinai in 1973 and Chief of Surgery in 1975. He was the orthopaedic surgeon for the Toronto Blue Jays from 1981-2017, serving as a member of the 1992 and 1993 World Series teams. He was appointed to the Order of Canada in 2022 for “significant advancements in bone and cartilage transplantation as a renowned orthopaedic surgeon, educator and researcher.”
Allan Gross put Mount Sinai on the world map as a trailblazer in complex orthopaedics. We wouldn’t be where we are today, without his leadership.
Dr. Jay S. Wunder, former Surgeon-in-Chief, Sinai Health
About Mount Sinai 100 Chairs
In 2023, Mount Sinai Hospital will mark its 100th anniversary. To honour the physicians and scientists who have made breakthrough discoveries and whose achievements have elevated Sinai Health’s reputation for world-class care, we are pleased to introduce our Mount Sinai 100 Chairs. These legacy chairs carry the names of Sinai Health’s most eminent trailblazers and will help recruit and fund the work of a new generation of clinicians and scientists, securing the next century of caring at Sinai Health. We invite you to help us imagine the next 100 years.
About Mount Sinai 100 Chairs
In 2023, Mount Sinai Hospital will mark its 100th anniversary. To honour the physicians and scientists who have made breakthrough discoveries and whose achievements have elevated Sinai Health’s reputation for world-class care, we are pleased to introduce our Mount Sinai 100 Chairs. These legacy chairs carry the names of Sinai Health’s most eminent trailblazers and will help recruit and fund the work of a new generation of clinicians and scientists, securing the next century of caring at Sinai Health. We invite you to help us imagine the next 100 years.
About Mount Sinai 100 Chairs
In 2023, Mount Sinai Hospital will mark its 100th anniversary. To honour the physicians and scientists who have made breakthrough discoveries and whose achievements have elevated Sinai Health’s reputation for world-class care, we are pleased to introduce our Mount Sinai 100 Chairs. These legacy chairs carry the names of Sinai Health’s most eminent trailblazers and will help recruit and fund the work of a new generation of clinicians and scientists, securing the next century of caring at Sinai Health. We invite you to help us imagine the next 100 years.
